CN103948651A - Application of freezing technology in drying of lucid ganoderma - Google Patents

Application of freezing technology in drying of lucid ganoderma Download PDF

Info

Publication number
CN103948651A
CN103948651A CN201410204837.8A CN201410204837A CN103948651A CN 103948651 A CN103948651 A CN 103948651A CN 201410204837 A CN201410204837 A CN 201410204837A CN 103948651 A CN103948651 A CN 103948651A
Authority
CN
China
Prior art keywords
dry
ganoderma
freezing
application
drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410204837.8A
Other languages
Chinese (zh)
Inventor
卢宁
郭庆华
冯立娟
丁桂丽
孙志芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Original Assignee
Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Kangzhong Pharmaceutical Research and Development Co Ltd filed Critical Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Priority to CN201410204837.8A priority Critical patent/CN103948651A/en
Publication of CN103948651A publication Critical patent/CN103948651A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to application of the freezing technology in drying of lucid ganoderma. According to the preparation, fresh lucid ganoderma is picked and then treated by freezing, piling for 2 to 5 days and drying; the prepared lucid ganoderma is high in content of active ingredient, namely, polysaccharide, and also high in anti-cancer activity.

Description

The application of Refrigeration Technique in Ganoderma is dry
Technical field
The present invention relates to medicine method for making, the particularly application of Refrigeration Technique in Ganoderma is dry, belongs to medical technical field.
Background technology
Ganoderma is On Polyporaceae Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganodermalucidum (Leyss.ExFr.) Karst. or Ganoderma GanodermasinenseZhao, the dry sporophore of XuetZhang.There is invigorating QI and tranquilization, the effect of relieving cough and asthma, for dizzy sleeplessness, shortness of breath and palpitation, asthenia cough with asthma.Modern study proves, Ganoderma contains aminoacid, polypeptide, protein, and saccharide, ergosterol, triterpenes etc.Have and calm the nerves, regulate immunity, resist myocardial ischemia, anti-antiplatelet aggregation and antithrombotic, protect the liver, antioxidation, antiinflammatory, antitumor action.
What < < Chinese Pharmacopoeia > > recorded gathers and processing method, gather the whole year, remove impurity, wipe out the lower end stem with rotten wood, silt or culture matrix, dry in the shade or 40~50 ℃ of oven dry.
Summary of the invention
The drying means that the object of this invention is to provide a kind of Ganoderma, the Ganoderma that the method is dry, main effective ingredient polyoses content is high, and active anticancer is strong.
The present invention is achieved in that
The application of Refrigeration Technique in Ganoderma is dry, is characterized in that: get the Ganoderma of newly gathering, and freezing, the 2-5 days that banks up is dry.
The application of Refrigeration Technique of the present invention in Ganoderma is dry, is characterized in that: freezing is to be refrigerated to freeze.
The application of Refrigeration Technique of the present invention in Ganoderma is dry, is characterized in that: freezing is to be refrigerated to-5 ℃ to freeze below.
The application of Refrigeration Technique of the present invention in Ganoderma is dry, is characterized in that: dry is that heap postpone is dried or dries or dries.
Of the present inventionly being refrigerated to subzero certain ℃, is to be refrigerated to and to freeze at this subzero certain ℃.
So far completed the present invention, the Ganoderma of preparing by drying means of the present invention, main effective ingredient polyoses content is high, and active anticancer is strong.
Below by test example, further illustrate usefulness of the present invention, test example is intended to further illustrate usefulness of the present invention, but not limitation of the present invention.
By with a collection of Ganoderma of newly gathering, remove impurity, process by the following method.
1) dry: shady and cool ventilation place, spread out and dry;
2) dry: dry;
3) dry: 50 ℃ of following oven dry;
4) the freezing oven dry of banking up: be refrigerated to-5 ℃ to freezing, bank up 3 days at dark and damp place, 50 ℃ of following oven dry.
One, the dry ganoderma polyoses content comparison of distinct methods
The preparation of reference substance solution: get glucose reference substance appropriate, accurately weighed, add water and make every 1ml containing the solution of 0.1mg, obtain.
The preparation of standard curve: precision measures reference substance solution 0.2ml respectively, 0.4m1, 0.6ml, 0.8ml, 1.0ml, 1.2ml, put in 10ml tool plug test tube, add water to 2.0ml, precision adds sulphuric acid anthrone solution, and (precision takes anthrone 0.1g, adding 80% sulfuric acid solution 100ml makes to dissolve, shake up) 6ml, shake up, put in water-bath and heat 15 minutes, take out, put in people's ice bath cooling 15 minutes, take corresponding reagent as blank, according to < < Chinese Pharmacopoeia > > ultraviolet visible spectrophotometry, at 625nm wavelength place, measure absorbance, take absorbance as vertical coordinate, concentration is abscissa, drawing standard curve.
The preparation of need testing solution: get the about 2g of each sample powder, accurately weighed, put in apparatus,Soxhlet's, add water 90ml, electric heater heating and refluxing extraction is to extracting liquid colourless, and extracting solution is transferred in 100ml measuring bottle, adds water to scale, shaking up. precision measures 10ml, adds ethanol 150ml, shakes up, place 12 hours for 4 ℃, take out, centrifugal, the supernatant that inclines, precipitation is dissolved in water, and is transferred in 50ml measuring bottle, add water to scale, shake up, obtain.
Algoscopy: precision measures need testing solution 2ml, put in 10ml tool plug test tube, method under the preparation of sighting target directrix curve, from " precision adds sulphuric acid anthrone solution 6ml ", measure absorbance in accordance with the law, from standard curve, read the weight (mg) that contains glucose in need testing solution, calculate, obtain.
Press dry product and calculate, contain ganoderan with anhydrous glucose (C 6h1 2o 6) meter, the results are shown in Table 1.
Table 1 distinct methods is dried ganoderma polyoses content (%)
Drying means Dry Dry Dry The freezing oven dry of banking up
Content (%) 1.76 1.74 1.74 3.26
By table 1, found out, Ganoderma " freezing heap postpone is dry ", polyoses content is apparently higher than " drying ", " drying " and " oven dry ".
Two, the dry anti-human lung of Ganoderma source adenocarcinoma cell SPCA-1, human hepatoma cell line HepG2 and the people's chronic myelogenous leukemia cell K562 test of distinct methods.
1, prepare Ganoderma extract and get respectively the dry Ganoderma pulverizing of distinct methods, respectively decoct with water twice, add for the first time 8 times of amounts of water, decoct 2 hours, add for the second time 8 times of amounts of water, decoct 1 hour, merge medicinal liquid, medicinal liquid filters, and gets filtrate, and being concentrated into relative density is 1.10(60 ℃) time, add ethanol to make to reach 75% containing alcohol amount, precipitation, standing 36 hours, draw supernatant, reclaim ethanol, concentrated, dry, pulverize, obtain the dry Ganoderma extract of distinct methods.
2, tumor cell line people lung source adenocarcinoma cell SPCA-1, human hepatoma cell line HepG2 and people's chronic myelogenous leukemia cell K562, use RPMI-1649 culture fluid, and 37 ℃, 5%CO2, relative humidity 100% is cultivated, and attached cell 0.25% trypsinization goes down to posterity.
3, the inhibitory action of method MTT colorimetric method for determining extract to growth of tumour cell.The trophophase cell of taking the logarithm, is mixed with cell suspension with fresh RPMI-1640 culture fluid, 0.8 * 105/ml of 1 * 105/ml of suspension cell attached cell.Suspension cell is inoculated in 96 well culture plates after adding respectively variable concentrations Experimental agents; Attached cell is first inoculated in 96 well culture plates, after every hole 90 μ l24h, adds respectively variable concentrations Experimental agents.Final volume is that every hole 100 μ l and every group are established 3 parallel holes, establishes altogether 4 groups: be subject to reagent group T (culture fluid+cell suspension+variable concentrations is subject to reagent), negative control group N (culture fluid+cell suspension), medicine color matched group TC (culture fluid+variable concentrations is subject to reagent), blank group B (culture fluid+normal saline).Tested concentration is followed successively by 10 μ g/ml, 30 μ g/ml, 50 μ g/ml.Put 37 ℃, in 5%CO2 incubator, cultivate after 72h, after adding the 10 μ l concussions of MTT solution to mix to every hole, continue to cultivate 4h, add SDS90 μ l to stop cultivating, 37 ℃ are spent the night, and then under room temperature, on micro oscillator, shake 10min, microplate reader is measured the absorbance (OD value) at 570nm wavelength place, and experiment repeats 3 times.
Calculate as follows growth inhibition ratio:
Growth inhibition ratio (%)=(N group OD average-B group OD average)-(T group OD average-TC group OD average)/N group OD average-B group OD average * 100%.
4, different extracts to the suppression ratio of people's lung source adenocarcinoma cell SPCA-1, human hepatoma cell line HepG2 and people's chronic myelogenous leukemia cell K562 the results are shown in Table 2, table 3, table 4.
The suppression ratio result of table 2 couple SPCA-1
Suppression ratio (%) 10(μg/ml) 30(μg/ml) 50(μg/ml)
Dry 46.52 53.42 66.51
Dry 46.50 53.42 66.50
Dry 46.47 53.50 66.53
The freezing oven dry of banking up 57.68 71.38 79.64
The suppression ratio result of table 3 couple HepG2
Suppression ratio (%) 10(μg/ml) 30(μg/ml) 50(μg/ml)
Dry 43.62 54.74 58.67
Dry 43.59 54.74 58.66
Dry 43.61 54.71 58.64
The freezing oven dry of banking up 56.48 67.49 83.16
The suppression ratio result of table 4 couple K562
Suppression ratio (%) 10(μg/ml) 30(μg/ml) 50(μg/ml)
Dry 57.29 68.44 74.65
Dry 57.28 68.45 74.65
Dry 57.31 68.42 74.62
The freezing oven dry of banking up 64.38 73.75 83.02
Result shows, the dry Ganoderma of distinct methods all has inhibitory action to the propagation of SPCA-1, HepG2, K562 cell, wherein, freezingly banks up that to dry curative effect best.
The specific embodiment
embodiment 1
Get the Ganoderma of newly gathering, put in freeze dryer, be refrigerated to-5 ℃ to freezing, at dark and damp place, bank up 2 days, dry.
embodiment 2
Get the Ganoderma of newly gathering, put in freeze dryer, be refrigerated to-10 ℃, bank up in the cool 3 days, dry.
embodiment 3
Get the Ganoderma of newly gathering, put in freeze dryer, be refrigerated to-20 ℃, indoor, bank up 4 days, dry.
embodiment 4
Get the Ganoderma of newly gathering, put in freeze dryer, be refrigerated to-32 ℃ to freezing, outdoor, bank up 3 days, dry.
embodiment 6
Get the Ganoderma of newly gathering, put in freeze dryer, be refrigerated to-15 ℃, at dark and damp place, bank up 5 days, dry.

Claims (4)

1. the application of Refrigeration Technique in Ganoderma is dry, is characterized in that: get the Ganoderma of newly gathering, and freezing, the 2-5 days that banks up is dry.
2. the application in Ganoderma is dry according to the Refrigeration Technique of claim 1, is characterized in that: freezing is to be refrigerated to freeze.
3. the application in Ganoderma is dry according to the Refrigeration Technique of claim 1, is characterized in that: freezing is to be refrigerated to-5 ℃ to freeze below.
4. the application in Ganoderma is dry according to the Refrigeration Technique of claim 1, is characterized in that: dry is that heap postpone is dried or dries or dries.
CN201410204837.8A 2014-05-15 2014-05-15 Application of freezing technology in drying of lucid ganoderma Pending CN103948651A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410204837.8A CN103948651A (en) 2014-05-15 2014-05-15 Application of freezing technology in drying of lucid ganoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410204837.8A CN103948651A (en) 2014-05-15 2014-05-15 Application of freezing technology in drying of lucid ganoderma

Publications (1)

Publication Number Publication Date
CN103948651A true CN103948651A (en) 2014-07-30

Family

ID=51326093

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410204837.8A Pending CN103948651A (en) 2014-05-15 2014-05-15 Application of freezing technology in drying of lucid ganoderma

Country Status (1)

Country Link
CN (1) CN103948651A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103055022A (en) * 2013-01-10 2013-04-24 济南康众医药科技开发有限公司 Method for processing rehmannia and application for rehmannia in preparation for medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103055022A (en) * 2013-01-10 2013-04-24 济南康众医药科技开发有限公司 Method for processing rehmannia and application for rehmannia in preparation for medicine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
于才渊 王宝和 王喜忠编著: "《干燥装置设计手册》", 31 May 2005, 化学工业出版社 *
潘永康主编: "《现代干燥技术》", 30 September 1988, 化学工业出版社 *

Similar Documents

Publication Publication Date Title
CN103948652A (en) Method for drying lucid ganoderma
CN103977041A (en) Drying method of ganoderma applanatum pat
CN103977040A (en) Lucid ganoderma drying method
CN103948638A (en) Drying method of medical fungi
CN103977034A (en) Drying method of medicinal fungi
CN103948650A (en) Drying method of artist&#39;s conk
Moskova-Doumanova et al. Methanol and chloroform extracts from Lamium album L. Affect cell properties of a549 cancer lung cell line
CN102657674B (en) Application of Trichoderma pseudokoningii extracellular polysaccharides having anticancer activities
CN104083522A (en) Processing method of fresh solanum nigrum fruit, solanum nigrum fruit extract particles and use of solanum nigrum fruit extract particles
CN105712963B (en) A kind of coumarin dimer and its preparation method and application
CN103845420A (en) Rheum nobile extract and application thereof
CN104922268B (en) A kind of method that active material is extracted from natural plants
CN103948651A (en) Application of freezing technology in drying of lucid ganoderma
CN103977036A (en) Drying method of inonotus obliquus
CN104138403A (en) Drying method of radix tetrastigme
CN101766662B (en) Process for efficiently concentrating cordycepin
CN105379887A (en) Sweet osmanthus flowers tea with optimal antioxidation synergistic effect and preparation method as well as use thereof
CN101735330A (en) Preparation method of yew polysaccharide with function of resisting tumors and application thereof
CN103948648A (en) Application of freezing technology in drying medicinal fungi
CN103977042A (en) Application of refrigeration technology for drying Ganoderma applanatum
CN103550323A (en) Traditional Chinese medicine extract with antitumor activity as well as preparation method and use thereof
CN103285046B (en) Auricularia polytricha protein extract and anti-tumor application thereof
CN103272216B (en) Pleurotus citrinopileatus protein extract and antineoplastic application thereof
CN105394770A (en) Application of osmanthus tea having optimal antioxidant synergistic effect to preparation of anticancer health care products or food
CN105379888A (en) Application of osmanthus tea with optimal antioxidation synergistic effect in preparation of health care products or food for regulating blood sugar level

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140730